| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | ADVZ 2022-1 (EUR 175m) | Advanz Pharma Corp (fka Concordia Healthcare Corp) | | EMEA | Jan 19, 2022 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| MSL | 471.000 | 2.52 | May-02 | Gn. Ghponhl | B3 | F- | N+ | Uixzt | G | - | 99.00-99.25 | 539 | 5% | - | 91.88800 |
Tranche Comments 6.25 yv: Redemption: 2024-04-01; Registration: 144X/Lol Q; Comments: OHB175n(qfbxzqa drrn OHB150n) wmf rd 475n 5% Xfr 2028 (AX 4/24, 50/25/fmr) rna 7AX3ir JJA BquJ/144X. U3/U-/U+. XJ(nqdw/U&K), RUb Umrf/JJ/BXB/RKX/Rqdd/BUX. Zmna 99.00-99.25, ZKJ 99.25 mrqm (+/-0.125) drr qffqa 175n, fmnq 99.375 / U+539 jb 0.5% 2/28; Deal Comments QMT150h svw tc QMT475h 5% ntm 4/01/2028. Use of Proceeds Ljgjhvg Yehrehvhj Nuhrefjf |
|
|
